Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 9/20 | 0.58 |
| ▸ | ITGA2B | P08514 | 9/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.53 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.46 |
| ▸ | MDM4 | O15151 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | ITGAV | P06756 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31000632 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BPTPN1MDM2SUCNR1 | |
| SCHEMBL2022391 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BPTPN1MDM2SUCNR1 | |
| SCHEMBL25356527 | 1.00 | ITGB3 (0.58) | ITGB3ITGA2BPTPN1MDM2SUCNR1 | |
| SCHEMBL13762822 | 0.97 | ITGB3 (0.60) | ITGB3ITGA2BPTPN1MDM2SUCNR1 | |
| SCHEMBL31688591 | 0.97 | ITGB3 (0.60) | ITGB3ITGA2BPTPN1MDM2SUCNR1 | |
| SCHEMBL25357497 | 0.89 | ITGB3 (0.54) | ITGB3ITGA2BMDM4TP53 | |
| SCHEMBL25357491 | 0.89 | ITGB3 (0.54) | ITGB3ITGA2BMDM4TP53 | |
| SCHEMBL25355380 | 0.88 | MDM2 (0.46) | ITGB3ITGA2BPTPN1MDM2MDM4 | |
| SCHEMBL25355374 | 0.88 | MDM2 (0.46) | ITGB3ITGA2BPTPN1MDM2MDM4 | |
| SCHEMBL31369591 | 0.88 | ITGB3 (0.54) | ITGB3ITGA2BPTPN1MDM2MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | ITGB3 4142/4885ITGA2B 3266/4885PTPN1 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.